Safely Administering Lutetium Lu 177 Dotatate to Patients With Neuroendocrine Tumors
An overview of safe handling concerns regarding handling and administration of a recently approved receptor-binding radionuclide.
Radiotherapy
Guidelines Updated for Radiotherapy After Prostatectomy
Updates include adjuvant radiotherapy for patients with adverse pathologic findings, hormonal therapies.
Radiotherapy Tied to Lower Recurrence of Early, Hormone-Driven Breast Cancer
Antihormone treatment also recommended in conjunction with radiotherapy.
Postchemo Radiation Tx May Benefit Some With Hodgkin Lymphoma
Survival benefit seen for radiotherapy after ABVD regimen, but difference not statistically significant.
Prostate Cancer Mortality Lowest With Radical Prostatectomy
In a study with a follow-up period of 18 years, men treated with any other modality but radical prostatectomy had higher prostate cancer death risks.
Role of Radiotherapy in the treatment of Metastatic Head and Neck Cancer
[OncoTargets and Therapy] A review of the role of radiation therapy and potential prognostic factors for selecting patients for more radical treatment.
Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
[Breast Cancer: Targets and Therapy] A review of the potential of immunotherapy along and in combination with standard therapies for breast cancer, in particularly HER2-positive expressing subtypes.
Light Use of Topical Skin Treatments Before Radiotherapy Appears Safe
Radiation dose not impacted with light or moderate use of skin treatments, regardless of beam energy, incidence.
Hypofractionated Radiotherapy After Conservative Surgery May Increase Low-intermediate Grade Late Fibrosis in Breast Cancer Patients
[Breast Cancer: Targets and Therapy] Researchers sought to determine the incidence of subcutaneous side effects in patients with early-stage breast cancer treated with AHF-RT vs standard fractionated RT after breast conserving surgery.
Is Radioimmunotherapy a Path Forward for Melanoma?
Recent research implicates patients’ immune cells appear to stimulate radiation abscopal effects, raising the possibility that combining radiotherapy and immunotherapy could yield previously-untapped treatment synergies to improve tumor control.
Next post in Melanoma
